Clinical Trials Browser

Unknown × Neoplasms × Imatinib Mesylate × Clear all

NCT02461849 2022-06-15

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

Phase 2 Unknown

Neoplasms

NCT03381053 2017-12-21

Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation

Neoplasms